First FDA-cleared computerized test of cognitive function will be evaluated in the Bio-Hermes study; seeks to improve identification and screening…
Dr. Fred Ma addresses the COVID-19 pandemic and the role of cognitive testing. Cognivue CMO Newsletter, Fall 2020
Cognivue, Inc. has named Fred Ma, MD, PhD, as it’s Chief Medical Officer and Senior Vice President, effective immediately. His nearly four-decade career spans global medical device and pharmaceutical development and commercialization,…
We are excited to announce that Cognivue’s peer-reviewed article, “Validity, reliability and psychometric properties of a computerized cognitive assessment” was published in the World Journal of Psychiatry (WJP). Cognivue is an important…
Cognivue announces the appointment of two key leaders. Joining the company are Dr. Reina Benabou, MD, PhD, as Senior Vice President and Chief Medical Officer and Whitney Parachek as Vice President of…
Please call 716-250-2000 and make your mandatory reservation today! Dent is the largest outpatient Neurologic Institute in the Country. Cognivue is proud to be a featured sponsor of this event. Commercial
Local news reporter, Ashley Doerzbacher, visited our office in Victor, New York to learn about Cognivue and how the test identifies changes in cognitive function and can be used as an early indicator of…
Victor-based company measures cognitive function with first FDA-cleared digital test ROCHESTER, N.Y., July 10, 2018—Victor-headquartered Cognivue, Inc., owned by Tom Golisano, is positioning itself for the rapid expansion of its Cognivue system….
Come see our booth at the Michigan Family Practice Conference, July 12-13. The conference will be held at the Radisson Plaza Hotel at Kalamazoo Center, 100 West Michigan Ave., Kalamazoo, MI 49007.
October 7th, 2021 WXXI’s Randy Gorbman reports on Cognivue, Inc. with an interview with Cognivue’s President and CEO, Tom O’Neill. Read & Listen
